Clinical trial

Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related…

NCT00496080 · Ethicon, Inc., Industry · Terminated

Key facts

NCT number NCT00496080
Title Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding
Official title A Pivotal Study of Doppler Guided Uterine Artery Occlusion as Treatment for the Reduction of Fibroid Associated Bleeding
Acronym DUAO
Lead sponsor Ethicon, Inc., Industry
Status Terminated
Study type Interventional
Conditions Menorrhagia, Uterine Fibroids
Intervention type Device
Interventions Doppler-Guided Uterine Artery Occlusion Device (DUAO)
Enrollment 87
Start date Jun 1, 2007
Primary completion Sep 1, 2010
Completion Oct 1, 2010
First posted Jul 4, 2007
Last update posted Sep 10, 2012
Countries Canada, Mexico, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies